Clinical Trials Browser

Recruiting × Interventional × Clinical Trials, Phase II as Topic × Clear all

NCT07357519 2026-02-09

Lu-TARGO (177Lu-TARGeted Osteosarcoma Therapy)

Phase 1/2 Recruiting

Osteosarcoma

NCT04752722 2026-01-26

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Phase 1/2 Recruiting

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ

NCT04199741 2026-01-07

PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56

Phase 1/2 Recruiting

Small Cell Lung Carcinoma

NCT05958121 2025-11-18

IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors

Phase 1/2 Recruiting

Neoplasms, Recurrence

NCT06364956 2025-08-11

Clinical Trail of Neoadjuvant of Tislelizumab Combined With Palbociclib in Patients With Platinum-refractory Bladder Urothelial Carcinoma

Phase 1/2 Recruiting

Urinary Bladder Neoplasms

NCT05491083 2025-07-25

ComPACT

Phase 1/2 Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06578624 2025-06-05

Safety and Preliminary Efficacy of SA53-OS in Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1/2 Recruiting

Liposarcoma

NCT04503265 2025-05-01

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

Phase 1/2 Recruiting

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Disease Progression

NCT06464055 2025-02-10

A Study of GQ1010 in Subjects With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Malignant Solid Tumors

NCT05953350 2024-12-03

A Phase Ib/II Study Confirmed Inhibition of Autophagy Synergizes Anti-tumor Effect of High Dose CDK4/6i

Phase 1/2 Recruiting

Inhibition of Autophagy Synergizes Anti-tumor Effect

NCT04679454 2024-08-05

Single Fraction Preoperative Radiotherapy for Early Stage Breast Cancer

Phase NA Recruiting

Breast Neoplasms